Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;30(3):e70012.
doi: 10.1111/nep.70012.

Challenges of Managing Lupus Nephritis in an Emerging Nephrology Centre: A Fijian Cohort Study

Vishal Kumar  1 , Yogeshni Chandra  2 , Sabiha Khan  3 , Mai Ling Perman  4 , Angus Ritchie  5   6 , Shilpanjali Jesudason  7 , Anis Ta'eed  1
Affiliations

Challenges of Managing Lupus Nephritis in an Emerging Nephrology Centre: A Fijian Cohort Study

Vishal Kumar et al. Nephrology (Carlton). 2025 Mar.

Abstract

Aim: To characterise the epidemiology and outcomes of Lupus Nephritis (LN) in Fiji.

Methods: All adult LN cases diagnosed from 2016 to 2020 at the national referral hospital were included. Treatment response, kidney failure, dialysis dependence and death were reported.

Results: From 33 cases, a crude annual incidence of 2.44 (95% CI 1.73-3.43) per 100,000 population and an age-standardised incidence of 2.37 (95% CI 0.65-4.09) per 100,000 population was derived. The median age was 25.7 years (IQR 19.5-32) with a predominance of indigenous iTaukei ethnicity (67%). Kidney biopsy with adequate tissue was performed in 24 patients (73%), revealing LN class III in 10 patients (42%) and class IV in 14 patients (58%). Twenty-eight patients (85%) underwent induction immunosuppression, with complete and partial response in 12 patients (43%) and 2 patients (7%) at 12 months, respectively. No factor was found to be significantly associated with complete response at 12 months. At 2 years, 13 patients (39%) had developed kidney failure, 6 of whom commenced dialysis, and 13 patients (39%) had died. The risk of dialysis dependence or death was associated with suboptimal adherence to therapy (OR 12.0, 95% CI 1.23-117, p = 0.028) and 12-month complete response (OR 0.08, 95% CI 0.01-0.54, p = 0.005).

Conclusion: Fiji has a high incidence of LN and nearly half of our cohort had either died or were dialysis dependent within 2 years of diagnosis. These results will inform targeted healthcare strategies that can be implemented in Fiji and neighbouring Pacific Island countries.

Keywords: Fiji; Pacific Islands; incidence; lupus nephritis; systemic lupus erythematosus.

PubMed Disclaimer

References

    1. S. Almaani, A. Meara, and B. H. Rovin, “Update on Lupus Nephritis,” Clinical Journal of the American Society of Nephrology 12, no. 5 (May 2017): 825–835.
    1. J. G. Hanly, A. G. O'Keeffe, L. Su, et al., “The Frequency and Outcome of Lupus Nephritis: Results From an International Inception Cohort Study,” Rheumatology (Oxford, England) 55, no. 2 (February 2016): 252–262.
    1. C. Mendoza‐Pinto, I. Etchegaray‐Morales, and M. F. Ugarte‐Gil, “Improving Access to SLE Therapies in Low and Middle‐Income Countries,” Rheumatology (Oxford, England) 62, no. Suppl 1 (March 2023): i30–i35.
    1. A. Delarche, C. Lumbroso, A. Fournier, et al., “Incidence and Outcome of Lupus Nephritis in French Polynesia,” Clinical Nephrology 89, no. 1 (January 2018): 41–49.
    1. F. Burling, J. Ng, H. Thein, J. Ly, M. R. Marshall, and P. Gow, “Ethnic, Clinical and Immunological Factors in Systemic Lupus Erythematosus and the Development of Lupus Nephritis: Results From a Multi‐Ethnic New Zealand Cohort,” Lupus 16, no. 10 (October 2007): 830–837.

Substances

LinkOut - more resources